|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 239/22 | (2006.01) |
| C07D 239/54 | (2006.01) | ||
| C07D 401/10 | (2006.01) | ||
| C07D 403/10 | (2006.01) | ||
| C07D 405/10 | (2006.01) | ||
| C07D 409/10 | (2006.01) | ||
| C07D 413/10 | (2006.01) | ||
| C07D 417/10 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Number of the document | 2203431 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08832330.8 |
| Date of filing the European patent application | 2008-09-17 | |
| (97) | Date of publication of the European application | 2010-07-07 |
| (45) | Date of publication and mention of the grant of the patent | 2011-08-10 |
| (46) | Date of publication of the claims translation | 2012-01-25 |
| (86) | Number | PCT/US2008/076592 |
| Date | 2008-09-17 |
| (87) | Number | WO 2009/039134 |
| Date | 2009-03-26 |
| (30) | Number | Date | Country code |
| 972881 P | 2007-09-17 | US | |
| 96792 | 2008-09-13 | US |
| (72) |
FLENTGE, Charles, A., US
HUTCHINSON, Douglas, K., US
BETEBENNER, David, A., US
DEGOEY, David, A., US
DONNER, Pamela, L., US
KATI, Warren, M., US
KRUEGER, Allan, C., US
LIU, Dachun, US
LIU, Yaya, US
LONGENECKER, Kenton, L., US
MARING, Clarence, J., US
MOTTER, Christopher, E., US
PRATT, John, K., US
RANDOLPH, John, T., US
ROCKWAY, Todd, W., US
STEWART, Kent, D., US
WAGNER, Rolf, US
BARNES, David, M., US
CHEN, Shuang, US
FRANCZYK, Thaddeus, S., II, US
GAO, Yi, US
HAIGHT, Anthony, R., US
HENGEVELD, John, E., US
KOTECKI, Brian, J., US
LOU, Xiaochun, US
ZHANG, Geoff, G., Z., US
|
| (73) |
AbbVie Manufacturing Management Unlimited Company ,
70 Sir John Rogerson's Quay, Dublin 2,
IE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Priešinfekciniai pirimidinai ir jų panaudojimas |
| ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-08-09 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-09-17 |